- •Shortening antimicrobial treatments is essential to avoid the emergence of antibiotic resistance.
- •Duration of therapy for febrile urinary tract infections in men had not been well stablished.
- •Serum PSA could guide the duration of therapy based on prostatic involvement.
- •A short duration therapy (14 days) is a safe option in patients with normal serum PSA values.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- Epidemiology of symptomatic urinary tract infection in childhood.Acta Paediatr Scand Suppl. 1974; : 1-20https://doi.org/10.1111/j.1651-2227.1974.tb05718.x
- Febrile urinary tract infection in men.Int J Antimicrob Agents. 2003; 22: 89-93https://doi.org/10.1016/s0924-8579(03)00228-0
- How common is prostatitis? A national survey of physician visits.J Urol. 1998; 159: 1224-1228
- Population-based epidemiologic analysis of acute pyelonephritis.Clin Infect Dis. 2007; 45: 273-280https://doi.org/10.1086/519268
- Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.BJU Int. 1999; 84: 470-474https://doi.org/10.1046/j.1464-410x.1999.00164.x
- Treatment of bacterial prostatitis.Clin Infect Dis. 2010; 50: 1641-1652https://doi.org/10.1086/652861
- Stoking the antibiotic pipeline.Bmj. 2010; 340: c2115https://doi.org/10.1136/bmj.c2115
- Antibiotics and the gut microbiota.J Clin Invest. 2014; 124: 4212-4218https://doi.org/10.1172/jci72333
- The New Antibiotic Mantra-"Shorter Is Better".JAMA Intern Med. 2016; 176: 1254-1255https://doi.org/10.1001/jamainternmed.2016.3646
- Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up.Scand J Infect Dis. 2003; 35: 34-39https://doi.org/10.1080/0036554021000026988
- Therapy of recurrent invasive urinary-tract infections of men.N Engl J Med. 1979; 301: 878-880https://doi.org/10.1056/nejm197910183011607
- Recurrent urinary tract infections in men. Characteristics and response to therapy.Ann Intern Med. 1979; 91: 544-548https://doi.org/10.7326/0003-4819-91-4-544
- Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.Scand J Infect Dis Suppl. 1986; 48: 48-53
- Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.BMC Med. 2017; 15: 70https://doi.org/10.1186/s12916-017-0835-3
- Selective urological evaluation in men with febrile urinary tract infection.BJU Int. 2001; 88: 15-20https://doi.org/10.1046/j.1464-410x.2001.02252.x
- Current concepts in the management of urinary tract infections in adults.Med Clin North Am. 1984; 68: 335-349https://doi.org/10.1016/s0025-7125(16)31134-8
- Urinary tract infection in men–state of the art.Infection. 1994; 22: S19-S21https://doi.org/10.1007/bf01716031
- A practical guide to antimicrobial management of complicated urinary tract infection.Drugs Aging. 2001; 18: 243-254https://doi.org/10.2165/00002512-200118040-00002
- Urinary tract infection in male veterans: treatment patterns and outcomes.JAMA Intern Med. 2013; 173: 62-68https://doi.org/10.1001/2013.jamainternmed.829
- Frequency and clinical significance of prostatic involvement in men with febrile urinary tract infection: a prospective observational study.F1000Res. 2020; 9: 617https://doi.org/10.12688/f1000research.24094.3